SCHEMBL5221011

SCHEMBL5221011

CCCc1cc(C(=O)OC)c(F)c(N2CCCS2(=O)=O)c1

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CTSD P07339 3/20 0.39
BACE1 P56817 3/20 0.39
BACE2 Q9Y5Z0 3/20 0.39
TP53 P04637 6/20 0.38
PIK3C3 Q8NEB9 2/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
POLB P06746 1/20 0.35
DRD2 P14416 2/20 0.34
MAPT P10636 1/20 0.34
PARP1 P09874 1/20 0.34
REV1 Q9UBZ9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5223859 0.97 CTSD (0.42) CTSDBACE1BACE2TP53PIK3C3
SCHEMBL5222900 0.87 CTSD (0.37) CTSDBACE1BACE2TP53PIK3C3
SCHEMBL5223868 0.86 CTSD (0.34) CTSDBACE1BACE2CYP3A4CYP2D6
SCHEMBL5221774 0.84 BACE1 (0.49) CTSDBACE1BACE2TP53PIK3C3
SCHEMBL5218901 0.84 BACE1 (0.40) CTSDBACE1BACE2TP53CYP3A4
SCHEMBL5226784 0.81 PIK3C3 (0.39) CTSDBACE1BACE2TP53PIK3C3
SCHEMBL5223775 0.81 KDM4E (0.39) CTSDBACE1BACE2TP53PIK3C3
SCHEMBL5219943 0.81 BACE1 (0.53) CTSDBACE1BACE2TP53CYP3A4
SCHEMBL5224667 0.79 PIK3C3 (0.37) CTSDBACE1BACE2TP53PIK3C3
SCHEMBL5224665 0.79 PIK3C3 (0.37) CTSDBACE1BACE2TP53PIK3C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-B1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2007-02-21 EP disclosed